我国各级医疗机构对儿童用基本药物剂型和规格的需求调查

发布时间：2018-04-20 23:25

本文选题：医疗机构 + 儿童　；参考：《中国循证医学杂志》2016年06期

【摘要】：目的调查各级医疗机构对儿童用基本药物的剂型、规格需求及需求异同,为分级遴选各级医疗机构需求的儿童基本药物目录提供方法学参考和决策依据。方法在全国范围内抽样调研13个省/自治区/直辖市的三级医疗机构、二级医疗机构、社区服务中心和乡镇卫生院104家,对比各级医疗机构间药品品种、剂型、需求类型、需求程度的差异。结果三级医疗机构的药品品种、剂型、需求类型需求量及对药物需求程度均高于其他各级医疗机构(P0.05),二级医疗机构高于社区服务中心和乡镇卫生院(P0.05),社区服务中心和乡镇卫生院需求一致(P0.05)。结论国内各级医疗机构对儿童用基本药物国外上市但国内缺乏、儿童适宜、临床急需剂型规格清单中各药品需求存在差异,后续研究可按医疗机构级别分级遴选、建立儿童适宜、临床急需的用药清单。
[Abstract]:Objective to investigate the formulations, specifications, requirements and similarities and differences of essential drugs for children in medical institutions at all levels, and to provide methodological reference and decision basis for grading and selecting the catalogues of essential drugs for children in all levels of medical institutions. Methods A total of 104 third-level medical institutions, second-level medical institutions, community service centers and township health centers in 13 provinces / autonomous regions / municipalities were sampled and investigated nationwide. The drug types, dosage forms and demand types among medical institutions at all levels were compared. Differences in the level of demand. Results the kinds and dosage forms of drugs in tertiary medical institutions, The demand types and the demand for drugs were higher than those of other medical institutions at all levels, while the level II medical institutions were higher than those of community service centers and township health centers. The demand of community service centers and township health centers was the same as that of township hospitals. Conclusion the medical institutions at all levels of the country market essential drugs for children abroad but lack of them in our country. The children are suitable for the use of essential drugs. There are differences in the requirements of each drug in the standard list of clinical dosage forms. The follow-up studies can be selected according to the level of medical institutions. Establish a list of suitable and urgently needed drugs for children.
【作者单位】：四川大学华西第二医院药学部;四川大学华西第二医院循证药学中心;出生缺陷与相关妇儿疾病教育部重点实验室;四川大学华西药学院;四川大学华西医院中国循证医学中心;四川大学华西第二医院儿科;
【基金】：国家自然科学基金(编号:81373381) 国家卫生计生委药物政策与基本药物制度司2014年委托课题
【分类号】：R95

【相似文献】